New Ways. New Innovations. New Paths Towards Disease Management.

Cancer is Hard. Testing for it Shouldn’t Be.

Cepheid’s innovative oncology program offers a growing menu of molecular diagnostic tests that currently focus on cancers of the breast, bladder, and blood. Harnessing the power of quantitative PCR technology and the world’s most popular molecular diagnostics platform1, Cepheid oncology products provide on-site, on-demand, standardized, and reliable results.

With Cepheid’s proven “lab in a cartridge,” our tests give patients and their doctors peace of mind when it matters most. The pioneering mindset of our oncology team is bolstered by Cepheid’s strong molecular biology capabilities, extensive global infrastructure, and an unwavering commitment to scientific rigor.

Oncology Products

Xpert® BCR-ABL Ultra

Xpert® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Discover a Better Path with Xpert BCR-ABL Ultra2

The high sensitivity of the Cepheid BCR-ABL test, Xpert BCR-ABL Ultra, allows for monitoring of disease even at low levels, thereby providing an essential aid for clinicians to manage their patients with CML, using IS-standardized molecular testing.

Visit the Xpert BCR-ABL Ultra Product Page Visit the Xpert BCR-ABL Ultra Product Page

Xpert BCR-ABL Ultra Resources:

In Here, We are Defining a New Era of Cancer Diagnostics

More than a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics with the GeneXpert® System. The complicated process of nucleic acid extraction, amplification and detection is all carried out within each single use cartridge. By making complex technology easy to use, our GeneXpert® cartridge has become the symbol of the Molecular Revolution. Using advanced microfluidics, all aspects of the testing process are handled within the cartridge chambers, minimizing the risk of cross contamination. Each cartridge is standardized and comes with internal controls, making running extra standard curves obsolete.

Our oncology tests quickly and accurately characterize multiple cancer markers using the same game changing system.

GeneXpert Resources

References

1. Based on July 2019 market research conducted by Kalorama Information with sample respondents in select countries.

2. CE IVD and US-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.